Tillkännagivande • Dec 31
Malion New Materials Co., Ltd. to Report Fiscal Year 2025 Results on Apr 22, 2026 Malion New Materials Co., Ltd. announced that they will report fiscal year 2025 results on Apr 22, 2026 Tillkännagivande • Sep 30
Malion New Materials Co., Ltd. to Report Q3, 2025 Results on Oct 25, 2025 Malion New Materials Co., Ltd. announced that they will report Q3, 2025 results on Oct 25, 2025 Tillkännagivande • Jul 02
Malion New Materials Co., Ltd. to Report First Half, 2025 Results on Aug 27, 2025 Malion New Materials Co., Ltd. announced that they will report first half, 2025 results on Aug 27, 2025 Tillkännagivande • Apr 23
Malion New Materials Co., Ltd., Annual General Meeting, May 13, 2025 Malion New Materials Co., Ltd., Annual General Meeting, May 13, 2025, at 14:00 China Standard Time. Location: The Company's Meeting Room, Shantou, Guangdong China Tillkännagivande • Mar 31
Malion New Materials Co., Ltd. to Report Q1, 2025 Results on Apr 23, 2025 Malion New Materials Co., Ltd. announced that they will report Q1, 2025 results on Apr 23, 2025 Tillkännagivande • Jan 24
Malion New Materials Co., Ltd. Announces Board Appointments Malion New Materials Co., Ltd. announced at the EGM held on January 22, 2025, approved election of Huang Kunyu as non-independent director; Shen Yiyong and Chen Xiaowei as independent director. Tillkännagivande • Dec 31
Malion New Materials Co., Ltd. to Report Fiscal Year 2024 Results on Apr 23, 2025 Malion New Materials Co., Ltd. announced that they will report fiscal year 2024 results on Apr 23, 2025 Tillkännagivande • Nov 22
Malion New Materials Co., Ltd. (SZSE:300586) and Yingkou Shenghai Investment Co., Ltd. signed Equity Transfer Agreement to acquire an additional 26.84% stake in Yingkou Yingxin Chemical Technology Co., Ltd. from Shandong Sinobioway Tianyuan Biotechnology Co., Ltd. for CNY 26.8 million. Malion New Materials Co., Ltd. (SZSE:300586) and Yingkou Shenghai Investment Co., Ltd. signed Equity Transfer Agreement to acquire an additional 26.84% stake in Yingkou Yingxin Chemical Technology Co., Ltd. from Shandong Sinobioway Tianyuan Biotechnology Co., Ltd. for CNY 26.8 million on November 19, 2024. A cash consideration of CNY 74.03 million will be paid by Malion New Materials Co., Ltd. and Yingkou Shenghai Investment Co., Ltd. Upon completion, Malion New Materials Co., Ltd. will own 49.89% and Yingkou Shenghai Investment Co., Ltd. will own 31.06% stake in Yingkou Yingxin Chemical Technology Co., Ltd.
As of June 30, 2024, Yingkou Yingxin Chemical Technology Co., Ltd. reported total assets of CNY 573.14 million and total common equity of CNY 336.05 million. The transaction is subject to approval of merger agreement by target board. The deal has been approved by the board. Reported Earnings • Oct 30
Third quarter 2024 earnings released: EPS: CN¥0.003 (vs CN¥0.015 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.003 (down from CN¥0.015 in 3Q 2023). Revenue: CN¥417.4m (down 2.5% from 3Q 2023). Net income: CN¥1.99m (down 82% from 3Q 2023). Profit margin: 0.5% (down from 2.5% in 3Q 2023). Tillkännagivande • Sep 30
Malion New Materials Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024 Malion New Materials Co., Ltd. announced that they will report Q3, 2024 results on Oct 30, 2024 New Risk • Sep 17
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Tillkännagivande • Jun 29
Malion New Materials Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024 Malion New Materials Co., Ltd. announced that they will report first half, 2024 results on Aug 30, 2024 Valuation Update With 7 Day Price Move • Jun 06
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CN¥6.51, the stock trades at a trailing P/E ratio of 52.7x. Average trailing P/E is 31x in the Chemicals industry in China. Total loss to shareholders of 44% over the past year. Tillkännagivande • May 25
Malion New Materials Co., Ltd. Announces Cash Dividend for the Year 2023, Payable on 30 May 2024 Malion New Materials Co., Ltd. announced the 2023 final profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included) of CNY 0.50000000. Record date: 29 May 2024. Ex-date: 30 May 2024. Payment date: 30 May 2024. Tillkännagivande • Apr 30
Malion New Materials Co., Ltd., Annual General Meeting, May 20, 2024 Malion New Materials Co., Ltd., Annual General Meeting, May 20, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Shantou, Guangdong China Reported Earnings • Apr 29
First quarter 2024 earnings released: EPS: CN¥0.037 (vs CN¥0.079 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.037 (down from CN¥0.079 in 1Q 2023). Revenue: CN¥420.2m (down 20% from 1Q 2023). Net income: CN¥26.5m (down 51% from 1Q 2023). Profit margin: 6.3% (down from 10% in 1Q 2023). The decrease in margin was driven by lower revenue. Valuation Update With 7 Day Price Move • Apr 17
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to CN¥6.70, the stock trades at a trailing P/E ratio of 30.7x. Average trailing P/E is 26x in the Chemicals industry in China. Total loss to shareholders of 43% over the past year. New Risk • Apr 08
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Profit margins are more than 30% lower than last year (8.3% net profit margin). Valuation Update With 7 Day Price Move • Apr 02
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to CN¥7.99, the stock trades at a trailing P/E ratio of 33.9x. Average trailing P/E is 30x in the Chemicals industry in China. Total loss to shareholders of 33% over the past year. Tillkännagivande • Mar 30
Malion New Materials Co., Ltd. to Report Q1, 2024 Results on Apr 29, 2024 Malion New Materials Co., Ltd. announced that they will report Q1, 2024 results on Apr 29, 2024 Valuation Update With 7 Day Price Move • Feb 23
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥6.23, the stock trades at a trailing P/E ratio of 26.4x. Average trailing P/E is 28x in the Chemicals industry in China. Valuation Update With 7 Day Price Move • Feb 01
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥5.86, the stock trades at a trailing P/E ratio of 24.7x. Average trailing P/E is 28x in the Chemicals industry in China. Tillkännagivande • Dec 30
Malion New Materials Co., Ltd. to Report Fiscal Year 2023 Results on Apr 29, 2024 Malion New Materials Co., Ltd. announced that they will report fiscal year 2023 results on Apr 29, 2024 Reported Earnings • Oct 26
Third quarter 2023 earnings released: EPS: CN¥0.015 (vs CN¥0.084 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.015 (down from CN¥0.084 in 3Q 2022). Revenue: CN¥427.9m (down 19% from 3Q 2022). Net income: CN¥10.8m (down 81% from 3Q 2022). Profit margin: 2.5% (down from 11% in 3Q 2022). The decrease in margin was driven by lower revenue. Reported Earnings • Aug 29
Second quarter 2023 earnings released: EPS: CN¥0.051 (vs CN¥0.15 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.051 (down from CN¥0.15 in 2Q 2022). Revenue: CN¥444.0m (down 31% from 2Q 2022). Net income: CN¥36.4m (down 64% from 2Q 2022). Profit margin: 8.2% (down from 16% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 31% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Valuation Update With 7 Day Price Move • Jun 28
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥12.39, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 15x in the Chemicals industry in China. Reported Earnings • Mar 29
Full year 2022 earnings released: EPS: CN¥0.60 (vs CN¥0.13 in FY 2021) Full year 2022 results: EPS: CN¥0.60 (up from CN¥0.13 in FY 2021). Revenue: CN¥2.40b (up 28% from FY 2021). Net income: CN¥317.1m (up 401% from FY 2021). Profit margin: 13% (up from 3.4% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Board Change • Mar 14
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Non Independent Director Haijiao Liu was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. 